17.11.2015,
8034 Zeichen
---------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a
Europe-wide distribution. The issuer is solely responsible for the
content of this announcement.
---------------------------------------------------------------
Financial Figures/Balance Sheet/quarterly report 17.11.2015
Stable positive company development with organic growth\nCapacity expansion and volume increases in the Industrial Sector\nMedical Sector benefits from strong sales and efficiency enhancements\nSatisfactory development expected for the entire year 2015\n The publicly listed Semperit Group generated positive revenue and
earnings in the first three quarters of 2015. Revenue increased by
5.5% to EUR 692.1 million compared with the prior-year period (EUR
655.9 million). The Industrial and Medical Sectors contributed to
this growth with a strong sales performance and increases in sales
volume. The net result (earnings after tax) increased by 7.9% to EUR
40.1 million (Q1-3 2014: EUR 37.1 million). Earnings per share rose
by 7.7% to EUR 1.95 (Q1-3 2014: EUR 1.81).
"The positive business development is the result of our
consistent activities in the past months. Contrary to the market
trend, we increased revenue based on a strong sales performance. Our
capacity expansion, an increased global presence and the rapid
integration of profile manufacturer Leeser are showing effect. At
the same time, we enhanced the profitability of the Medical Sector
through immediately effective optimisation measures, so that overall
the third quarter of 2015 already showed good results", CEO Thomas
Fahnemann comments on the current business development.
In the first three quarters of 2015, EBITDA amounted to EUR 80.5
million and EBIT to EUR 59.1 million. Due to changes in the
consolidation method in March 2014, the figures are not comparable
with the same period of the previous year.
The third quarter of 2015 was characterised by organic growth and
profitability increases. Semperit increased revenue by 13.6% to EUR
241.3 million(Q3 2014: EUR 212.3). EBIT increased by 18.7% to EUR
20.0 million (Q3 2014: EUR 16.9 million), and the net result
(earnings after tax) rose by 24.0% to EUR 14.7 million (Q3 2014: EUR
11.9 million). Accordingly, the EBIT margin improved from 7.9% to
8.3%.
Semperit has a solid capital base with an equity ratio of 38.0%
at 30 September 2015 (31 December 2014: 53.7%). Despite the payout
of a special dividend in May 2015, cash and cash equivalents
amounted to EUR 103.0 million compared to EUR 115.6 million at the
end of the year 2014. Semperit CFO Johannes Schmidt-Schultes on this
development: "We have high cash-generating power and a solid
financing base in the long term. We can afford an attractive
dividend policy while at the same time investing roughly 75 million
euros this year alone in the expansion and modernisation of our
factories. We will continue to pursue our growth strategy as
planned."
Medical Sector: Positive trend in earnings and profitability The
Medical Sector (Sempermed segment) generated higher sales volume
through intensified sales activities. This was contrasted by
negative price effects resulting from lower raw material prices as
well as up-front costs for the new factory in Malaysia.
Revenue of the Medical Sector rose by 1.8% to EUR 296.7 million
in the first nine months of 2015. The third quarter showed a clearly
positive development: The Medical Sector's revenue of EUR 105.2
million was 14.7% higher than in the same period of the previous
year. EBIT rose by 54.7% to EUR 6.8 million. The EBIT margin
improved to 6.4% in the third quarter (after 3.6% in Q2 and 4.3% in
Q1).
Industrial Sector: Strong performance in a weak environment The
Industrial Sector (Semperflex, Sempertrans and Semperform segments)
developed very well in contrast to the market trend.
The Semperflex segment's outstanding production and sales
performance has been the basis for further revenue growth and high
profitability in an overall declining market. At Europe's largest
hose factory, in Odry, Czech Republic, the new production capacities
are fully utilised. In the Sempertrans segment, the expansion to new
markets and segments led to significant increases in revenue and
earnings. The new capacities in the conveyor belt plant in
Be?chat�w, Poland, which were put into operations at the end of the
third quarter, are already well utilised. The Semperform segment
increased revenue and earnings in the double digit range despite
declining demand in important target markets. This is primarily
attributable to the successful integration of the profile
manufacturer Leeser as well as the beginning recovery of the
handrail business in China.
Revenue of the Industrial Sector rose by 8.5% to EUR 395.5
million in the first three quarters of 2015. The Sector's EBIT
increased by 15.3% to EUR 64.6 million. The EBIT margin rose to
16.3%. The third quarter contributed to this positive development
with an increase in revenue by 12.8% to EUR 136.2 million and a
21.5% increment in EBIT to EUR 20.7 million.
Outlook 2015 and multi-year targets The Semperit Group continues
to have strong order books as a result of intensified sales
activities in all segments. Despite an ongoing subdued market
development in Western Europe and North America the order intake
develops well. A slight recovery is recognisable in Central and
Eastern Europe, with the exception of Russia and Ukraine. The
difficult demand situation in Asia is expected to continue in the
coming months.
Semperit anticipates a satisfactory business development for the
remaining weeks of the year 2015 in a continued challenging business
environment. From today's perspective, revenue and earnings for the
year 2015 should be at an attractive level. A strong sales
performance, the currently high utilisation of production capacities
and successfully implemented projects to increase efficiency and
expand capacity, should continue to have a positive impact on
earnings in the coming quarters. These positive operating
developments are contrasted by the persisting difficult market
environment and start-up costs for new production capacities.
In the future, Semperit is striving to achieve double-digit
growth of sales volumes on average as well as attractive earnings
margins. For the time being, the targeted EBITDA margin remains
unchanged between 12% and 15% and the EBIT margin between 8% and
11%.
The report is now available for download:
www.semperitgroup.com/ir --> Reports and Presentations.
Photo Download:
https://semperitgroup.picturepark.com/Go/C4AhM4cR
About Semperit The publicly listed company Semperit AG Holding is
an internationally-oriented group that develops, produces, and sells
in more than 100 countries highly specialised rubber and plastic
products for the medical and industrial sectors: examination and
surgical gloves, hydraulic and industrial hoses, conveyor belts,
escalator handrails, construction profiles, cable car rings, and
products for railway superstructures. The headquarters of this
traditional Austrian company, which was founded in 1824, are located
in Vienna. The Semperit Group employs about 7,000 people worldwide,
including close to 4,100 in Asia and more than 800 in Austria
(Vienna and production site in Wimpassing, Lower Austria). The group
has 22 manufacturing facilities worldwide and numerous sales offices
in Europe, Asia, and America. In 2014 the group generated sales of
EUR 858 million and EBITDA of EUR 102 million.
end of announcement euro adhoc
---------------------------------------------------------------
issuer: Semperit AG Holding
Modecenterstrasse 22
A-1030 Wien
phone: +43 1 79 777-210
FAX: +43 1 79 777-602
mail: investor@semperitgroup.com
WWW: www.semperitgroup.com
sector: Synthetics & Plastics
ISIN: AT0000785555
indexes: WBI, ATX Prime, ViDX, Prime Market, ATX Global Players
stockmarkets: official market: Wien
language: English
Digital press kit:
http://www.ots.at/pressemappe/2918/aom
BSN Podcasts
Christian Drastil: Wiener Börse Plausch
Zertifikate Party Österreich 12/24: Diesmal kurze Party, 2025 startet dafür unser Real-Money-Zertifikate-Depot mit 14tägigen Podcasts
Semperit
Akt. Indikation: 11.88 / 12.06
Uhrzeit: 13:02:07
Veränderung zu letztem SK: 0.59%
Letzter SK: 11.90 ( -0.83%)
Bildnachweis
1.
Semperit-HV. Dienstag 29.4.2014. Tech-Gate
>> Öffnen auf photaq.com
Aktien auf dem Radar:Pierer Mobility, Warimpex, RHI Magnesita, Immofinanz, Addiko Bank, CA Immo, Mayr-Melnhof, Verbund, ATX, ATX Prime, ATX TR, Wienerberger, Kostad, EVN, Lenzing, Österreichische Post, Strabag, Athos Immobilien, AT&S, Cleen Energy, Marinomed Biotech, RWT AG, SBO, UBM, Agrana, Amag, Flughafen Wien, OMV, Palfinger, Telekom Austria, Uniqa.
UBM
Die UBM fokussiert sich auf Immobilienentwicklung und deckt die gesamte Wertschöpfungskette von Umwidmung und Baugenehmigung über Planung, Marketing und Bauabwicklung bis zum Verkauf ab. Der Fokus liegt dabei auf den Märkten Österreich, Deutschland und Polen sowie auf den Asset-Klassen Wohnen, Hotel und Büro.
>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner
Mehr aktuelle OTS-Meldungen HIER